Lyell Immunopharma, Inc.

Filed a patent for "immune cell therapy" on Fri, July 22, 2022

Filed a patent for "methods for culturing nr4a-deficient cells" on Fri, September 23, 2022

Filed a patent for "methods for culturing nr4a-deficient cells overexpressing c-jun" on Fri, September 23, 2022

Filed a patent for "methods for culturing nr4a-deficient cells" on Wed, October 5, 2022

Filed a patent for "methods for culturing immune cells" on Fri, October 14, 2022

Filed a patent for "polynucleotides targeting nr4a3 and uses thereof" on Mon, November 7, 2022

Filed a patent for "methods for culturing nr4a-deficient cells" on Mon, November 7, 2022

Filed a patent for "methods for culturing nr4a-deficient cells overexpressing c-jun" on Mon, November 7, 2022

Filed a patent for "methods for culturing nr4a-deficient cells" on Mon, November 7, 2022

Filed a patent for "polynucleotides targeting nr4a3 and uses thereof" on Thu, February 2, 2023

Filed a patent for "methods for culturing nr4a-deficient cells overexpressing c-jun" on Thu, February 2, 2023

Filed a patent for "methods for culturing nr4a-deficient cells" on Thu, February 2, 2023

Filed a patent for "methods for culturing nr4a-deficient cells" on Wed, April 26, 2023

Filed a patent for "methods for culturing nr4a-deficient cells overexpressing c-jun" on Wed, April 26, 2023

Filed a patent for "methods for culturing nr4a-deficient cells" on Wed, April 26, 2023

Filed a patent for "methods for culturing cells expressing c-jun" on Fri, May 6, 2022

Filed a patent for "methods for culturing cells expressing ror1-binding protein" on Fri, May 6, 2022

Filed a patent for "enhanced t cell therapy targeting ny-eso-1" on Fri, May 13, 2022

Filed a patent for "polynucleotides targeting nr4a3 and uses thereof" on Thu, May 19, 2022

Filed a patent for "nr4a3-deficient cells and uses thereof" on Thu, May 19, 2022

Filed a patent for "nr4a-deficient cells expressing c-jun and uses thereof" on Thu, May 19, 2022